LLY
ELI LILLY & Co
NYSE · Healthcare · Drug Manufacturers - General · US
$1,152.22
−0.02%Leverage
- Debt / equity
- 1.62x
- Net debt / equity
- 1.36x
- Debt / assets
- 0.39x
- Debt / EBITDA
- 1.27x
- Net debt / EBITDA
- 1.06x
Liquidity & coverage
- Current ratio
- 1.35x
- Quick ratio
- 1.00x
- Cash ratio
- 0.19x
- Interest coverage
- 40.43x
- EBITDA / interest
- 44.21x
- Working capital
- $16.9B
Cash & dividend
- FCF / debt
- 0.37x
- Cash flow / debt
- 0.51x
- Dividend per share
- $6.69
- Dividend yield
- 0.6%
- Dividend growth 1y
- +15.4%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026